$554 Million is the total value of Essex Woodlands Management, Inc.'s 7 reported holdings in Q2 2015. The portfolio turnover from Q1 2015 to Q2 2015 was 0.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| RVNC | REVANCE THERAPEUTICS INC | $146,854,000 | +54.3% | 4,592,047 | 0.0% | 26.51% | +40.4% | |
| ABMD | Sell | ABIOMED INC | $141,319,000 | -37.3% | 2,150,000 | -31.7% | 25.51% | -43.0% |
| CORI | CORIUM INTL INC | $128,047,000 | +109.0% | 9,353,304 | 0.0% | 23.11% | +90.2% | |
| ENTL | Buy | ENTELLUS MED INC | $98,647,000 | +18.1% | 3,813,197 | +0.0% | 17.80% | +7.5% |
| ELGX | ENDOLOGIX INC | $24,875,000 | -7.3% | 1,257,468 | 0.0% | 4.49% | -15.7% | |
| ACUR | Sell | ACURA PHARMACEUTICALS INC | $9,684,000 | +25.3% | 9,871,985 | -4.0% | 1.75% | +14.0% |
| MNOV | MEDICINOVA INC | $4,623,000 | +12.9% | 1,170,370 | 0.0% | 0.83% | +2.6% |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2015-08-11
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| MEDICINOVA INC | 42 | Q3 2023 | 6.5% |
| REVANCE THERAPEUTICS INC | 39 | Q3 2023 | 44.6% |
| AXOGEN INC | 26 | Q4 2021 | 43.3% |
| ENDOLOGIX INC | 24 | Q1 2019 | 22.5% |
| ABIOMED INC | 20 | Q1 2018 | 52.1% |
| CORIUM INTL INC | 20 | Q1 2019 | 23.5% |
| TELA BIO, INC. | 16 | Q3 2023 | 31.5% |
| VENUS CONCEPT, INC. | 16 | Q3 2023 | 21.3% |
| ACURA PHARMACEUTICALS INC | 15 | Q1 2019 | 1.4% |
| CATALYST BIOSCIENCES INC | 15 | Q1 2019 | 1.0% |
View Essex Woodlands Management, Inc.'s complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-14 |
| 13F-HR | 2023-05-15 |
| 13F-HR | 2023-02-14 |
| 13F-HR | 2022-11-14 |
| 13F-HR | 2022-08-15 |
| 13F-HR | 2022-05-16 |
| 13F-HR | 2022-02-14 |
| 13F-HR | 2021-11-15 |
View Essex Woodlands Management, Inc.'s complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.